10/19/2010 // West Palm Beach, FL, US // Sandra Quinlan // Sandra Quinlan
Fort Washington, PA—McNeil Consumer Healthcare, Division of McNeil-PPC, in cooperation with the U.S. Food and Drug Administration (FDA), voluntarily recalled one product lot of TYLENOL® 8 Hour caplets 50 count bottles to the retail level. The recall was initiated after McNeil received “a small number of complaints of a musty or moldy odor,” according to a Monday, October 18, 2010 news release.
According to McNeil Consumer Healthcare’s press release, which was published on the FDA’s Web site, “The uncharacteristic odor is thought to be caused by the presence of trace amounts of a chemical called 2,4,6-tribromoanisole.”
The recall was issued as a means of protecting consumers from adverse health affects that could potentially result from the consumption of the recalled caplets. Incidents reported to McNeil in connection with the TYLENOL® 8 Hour caplets were short-term and “non-serious.” The company described the risk of adverse medical events as “remote.”
The recall affects TYLENOL® 8 Hour caplets 50 count bottles with the lot number “BCM155” and UPC code “3 0045-0297-51 8.”
Consumers have been urged to cease use of the potentially dangerous Tylenol product and contact McNeil Consumer Healthcare at (888) 222-6036 (Monday-Friday 8 a.m. to 8 p.m. ET, and Saturday-Sunday 9 a.m. to 5 p.m. ET) or online at www.tylenol.com to find out how to receive a full reimbursement of product coupon.
Consumers with medical concerns are advised to contact their healthcare provider and report any adverse reactions to the FDA’s MedWatch Adverse Event Reporting program at www.fda.gov/medwatch/report.htm.
Legal News Reporter: Sandra Quinlan– Legal News for Product Liability Lawyers.
Media Information:
Address:
Phone: (866) 598-1315
Url: Sandra Quinlan: West Palm Beach Injury News
